Home › Multiple Sclerosis › Illinois › Champaign
Multiple Sclerosis clinical trials in Champaign, IL
4 studies for Multiple Sclerosis are looking for participants at sites in and around Champaign (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
RecruitingObservational study
- TG Therapeutics Investigational Trial Site, Urbana · 2 mi away
Fall Prevention Among People With Spinal Cord Injury and Multiple Sclerosis Who Use Wheelchairs and Scooters
Recruiting
- Disability Participation and Quality of Life (DPQOL) Laboratory, Urbana · 2 mi away
An Individualized-health eLibrary App for People With Multiple Sclerosis
Recruiting
- University of Illinois Urbana-Champaign, Champaign
Remote Evaluation of MIND Diet
Recruiting
- University of Illinois Urbana-Champaign, Urbana · 2 mi away
About Multiple Sclerosis
Multiple sclerosis (MS) slows down or blocks messages between the brain and body. MS can be mild or severe. Learn about MS symptoms and treatment.
More about Multiple Sclerosis on MedlinePlus
Multiple Sclerosis trials in other cities
- New York City, NY17 studies
- Chicago, IL15 studies
- Boston, MA14 studies
- Washington, DC13 studies
- Cleveland, OH10 studies
- Birmingham, AL9 studies
- Aurora, CO8 studies
- Kansas City, KS8 studies
- St. Louis, MO8 studies
- San Francisco, CA8 studies
- Tampa, FL7 studies
- Dallas, TX7 studies
Other studies in Champaign
- Breast Cancer11 studies
- Non-Small Cell Lung Cancer11 studies
- Lung Cancer9 studies
- Prostate Cancer8 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Melanoma6 studies
- Endometrial Cancer6 studies
- Colorectal Cancer6 studies
- Cancer (all types)5 studies
- Kidney Cancer (Renal Cell Carcinoma)5 studies
- Bladder Cancer5 studies
- Laryngeal Cancer5 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.